DLK1 and pheochromocytoma: Notably, DLK1 exhibits elevated expression levels in numerous common malignancies, including liver, breast, brain, pancreas, colon, and lung cancers, as well as endocrine-related cancers such as ovarian tumors and pheochromocytoma.